ROCHESTER — OptimizeRx Corp. (OTCQB:OPRX), an aggregator of pharmaceutical-sponsored services in electronic health records, appointed company director Gus D. Halas as chairman of the board, effective June 30. He will succeed retiring chairman and company founder, David Harrell.
As the company’s CEO until February of last year, Harrell created the first technology and network to automate customized copay savings and other patient support directly within doctors’ existing electronic prescribing workflow.
Continue reading OptimizeRx Names New Board Chair; Founding CEO To Retire
ROCHESTER — OptimizeRx Corp. (OTC: OPRX) said San Francisco, Calif.-based Merriman Capital has initiated coverage on the company’s stock, with a buy rating and a price target of $3.
Merriman notes that OptimizeRx provides software that lets drug companies communicate directly with doctors to promote their products. And the company is aggressively expanding its distribution network, “is aligned well with industry trends and addresses important gaps in the market.”
Continue reading OptimizeRx Gets Analyst Pickup